HCM pre-verapamil | HCM post-verapamil | Controls | |
Peak sCBFV (cm/s) | −11.2 (27.5)2-152 | −3.6 (31.8)2-151 | 18.7 (10.8) |
sVTI (cm) | −2.2 (4.9)2-152 | −1.2 (5.2)2-151 | 2.7 (1.7) |
Peak dCBFV (cm/s) | 59.9 (21.9)2-150 2-152 | 50.7 (19.5) | 41.8 (8.1) |
dVTI (cm) | 21.9 (10.1)2-150 2-152 | 17.1 (8.1) | 13.6 (2.6) |
Value are mean (SD).
↵2-150 p < 0.05 HCM pre-verapamil v HCM post-verapamil;
↵2-151 p < 0.05 HCM post-verapamilv controls;
↵2-152 p < 0.01 HCM pre-verapamilv controls.
dCBFV, diastolic coronary blood flow velocity; dVTI, diastolic velocity–time integral; HCM, hypertrophic cardiomyopathy; sCBFV, systolic coronary blood flow velocity; sVTI, systolic velocity–time integral.